Affordable Access

deepdyve-link deepdyve-link
Publisher Website

CCR9 and inflammatory bowel disease.

Authors
  • Koenecke, Christian
  • Förster, Reinhold
Type
Published Article
Journal
Expert Opinion on Therapeutic Targets
Publisher
Informa UK (Taylor & Francis)
Publication Date
Mar 01, 2009
Volume
13
Issue
3
Pages
297–306
Identifiers
DOI: 10.1517/14728220902762928
PMID: 19236152
Source
Medline
License
Unknown

Abstract

The therapeutic effects of CCR9 antagonists, in combination with established therapies, should be evaluated in an attempt to slow down leukocyte recruitment at early stages of IBD.

Report this publication

Statistics

Seen <100 times